SNOMED CT Templates

Page tree

StatusReady for implementation
Version

1.0

Version in PROD

Descriptions:

Termdescription typeLanguage/acceptabilityLanguage/acceptabilityCase significance

Harmful pattern of use of  [substance and/or product] (disorder)

FSNus:Pgb:Pci

Harmful pattern of use of  [substance and/or product]

SYNus:Pgb:Pci
[substance and/or product] abuseSYNus:Agb:Aci


Concept model:

Attribute Group CardinalityAttribute CardinalityAttribute cardinality in role groupAttributeValue
0..01..1

116680003 |Is a (attribute)|

74732009 |Mental disorder (disorder)|

0..1
0..1

263502005 |Clinical course (attribute)|

<  288524001 |Courses (qualifier value)|

1..1
0..1

246454002 |Occurrence (attribute)|

<  282032007 |Periods of life (qualifier value)|


1..1

246075003 |Causative agent (attribute)|


<  105590001 |Substance (substance)|  OR <  373873005 |Pharmaceutical / biologic product (product)|

1..1
1..1

363714003 |Interprets (attribute)|

<< 1187057000 |Substance use behavior (observable entity)|

Definition status:  


900000000000073002 |Defined (core metadata concept)|

Applies to:

<  1306692000 |Harmful pattern of substance use (disorder)|

Template language


Link to the misaligned concept report:

https://docs.google.com/spreadsheets/d/1nB8paYswgCkbBZERCo7XfPbdmqh7nG2MB857HJDV0nE/edit?gid=0#gid=0

Rules for description generation: 

  1. Apply General rules for generating descriptions for templates;
  2. Apply Enhancements for the Template Language;

JIRA ticket:

INFRA-13625 - Getting issue details... STATUS

EDITORIAL GUIDELINES for Causative agent (attribute):

Hierarchy

Concept type

Allowed

Exception

Examples and Notes

SubstanceBaseyesnone

Concepts representing a substance base should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.

Examples:

  • 724694006 |Harmful pattern of use of caffeine (disorder)|

Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy.

SubstanceModificationnonone

No use case has been identified for use of this concept type for modeling in this subhierarchy.

SubstanceStructure grouperyesnone

Concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.

  • 1737336003 |Synthetic cannabinoid abuse (disorder)|

Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy.

SubstanceDisposition grouperyesnone

Concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.

  • 5602001 |Opioid abuse (disorder)|

Classification results are expected to reflect that the adverse reaction concepts are descendants of the appropriate disposition grouper based on the modeling of the 726542003 |Has disposition (attribute)| attribute in the substance hierarchy.

SubstanceRole groupernonone

Concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.

  • 91388009 |Psychoactive substance abuse (disorder)|

Classification results are expected to reflect that the adverse reaction concepts are descendants of the appropriate disposition grouper based on the modeling of the 726542003 |Has disposition (attribute)| attribute in the substance hierarchy.

ProductMedicinal product-containingyesnone

Examples to be added - pending implementation of roles and products as causative agents

ProductRole grouperyesnone

Examples to be added - pending implementation of roles and products as causative agents

ProductStructure groupernonone

No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy.


ProductDisposition groupernononeNo use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy.
ProductMedicinal product-onlynononeNo use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy.
ProductMedicinal product form-containingnononeNo use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy.
ProductMedicinal product form-onlynononeNo use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy.
ProductClinical drugnononeNo use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy.

8 Comments

  1. Farzaneh Ashrafi

    Hi Yongsheng Gao

    As discussed in today's QI call, here is the draft template for Substance abuse concepts. I anticipate changes to the terming and modelling once the Mental and Behavioural Health Clinical Reference Group has finalized their decision regarding substance use/abuse/ misuse/ dependance etc:

    However, as noted during the call, this template can be used as a starting point and to making all current children consistent.

    Thanks,

    Farzaneh

    1. Yongsheng Gao

      Hi Farzaneh Ashrafi , I have updated the format for cardinalities and ranges aligned with template language. Please add the link to the alignment report.

      Cheers,

      Yong

      1. Farzaneh Ashrafi

        Hi Yongsheng Gao 

        Thanks for the review and update. I added the link to the alignment report.

        Thanks,

        Farzaneh

        1. Yongsheng Gao

          Hi Farzaneh Ashrafi , it looks good. Please go ahead making changes and normalisations. So, we can complete the QI work. 

  2. Elaine Wooler

    Hi,Farzaneh Ashrafi. Could you please review this and let me know if any changes are needed?

    Many thanks

    Elaine

  3. Farzaneh Ashrafi

    Hi Elaine Wooler 

    The updated template seems fine to me.

    Thanks,

    Farzaneh

  4. Elaine Wooler

    Hi Yongsheng Gao could you review this template please and see if it is ready to go into production.  Thanks.

    1. Yongsheng Gao

      Thanks Elaine Wooler  it is submitted to the technical team for implementation.